|
DHX8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.560200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.857600E-01 |
| Normal-vs-Stage2 |
7.126200E-01 |
| Normal-vs-Stage3 |
3.192000E-01 |
| Normal-vs-Stage4 |
2.446000E-01 |
| Stage1-vs-Stage2 |
8.979600E-01 |
| Stage1-vs-Stage3 |
5.758400E-01 |
| Stage1-vs-Stage4 |
5.132200E-01 |
| Stage2-vs-Stage3 |
6.168800E-01 |
| Stage2-vs-Stage4 |
5.242800E-01 |
| Stage3-vs-Stage4 |
8.279000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.013400E-01 |
| Normal-vs-AfricanAmerican |
2.792600E-01 |
| Normal-vs-Asian |
6.471800E-01 |
| Caucasian-vs-AfricanAmerican |
1.211630E-01 |
| Caucasian-vs-Asian |
9.508200E-01 |
| AfricanAmerican-vs-Asian |
2.214200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.002000E-02 |
| Normal-vs-Female |
6.253800E-01 |
| Male-vs-Female |
7.662400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.577000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.487000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.548600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.362000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.523600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.519600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.766200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.107600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.767000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.640000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.880400E-01 |
| Classical-VS-Follicular |
1.160390E-03 |
| Classical-VS-Other |
4.435600E-02 |
| Classical-VS-Normal |
9.130600E-01 |
| Tall-VS-Follicular |
1.778750E-01 |
| Tall-VS-Other |
1.068770E-01 |
| Tall-VS-Normal |
6.734200E-01 |
| Follicular-VS-Other |
4.255200E-01 |
| Follicular-VS-Normal |
2.104000E-02 |
| Other-VS-Normal |
3.182400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.459000E-01 |
| Normal-vs-N1 |
1.392580E-01 |
| N0-vs-N1 |
4.254000E-01 |
|
|
